McMillan Shakespeare Limited announced that Helen Kurincic will succeed Tim Poole as the Company's Chair at the conclusion of the upcoming Annual General Meeting on 20 October 2020. Tim will continue as a Non-Executive Director until October 2021. Helen joined the MMS Board in September 2018. She has deep senior executive and Board experience across the healthcare and related sectors. Helen is currently the Non-Executive Chair of Integral Diagnostics Limited, and a non-executive director of Estia Health Limited, HBF Health Limited and Victorian Clinical Genetics Services. Prior to taking on several Board roles, Helen was the Chief Operating Officer and Director of Genesis Care from its earliest inception, creating and developing the first and radiation oncology and cardiology business across Australia.